What is the 13F Pro Quality Score for CDLX?

13F Pro ranks Cardlytics, Inc. (CDLX) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View CDLX's current score at https://13fpro.ai/company/CDLX (free sign-up required for the full ranking).

Where does 13F Pro source CDLX data?

All Cardlytics, Inc. fundamentals and ownership data come directly from SEC EDGAR. Cardlytics, Inc. files with the SEC under CIK 1666071. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is CDLX in?

Cardlytics, Inc. (CDLX) is classified in the Technology sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/technology.

How often is CDLX research updated on 13F Pro?

CDLX's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

Cardlytics, Inc.(CDLX)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Technology →Nasdaqsmall

Institutional-grade research for retail investors

SEC EDGAR: CIK 1666071 CDLX stock profile & AI dashboard →

13F Pro Quality Score

19.4/100

Rank #2,795 of 2,962 stocks

View Technology peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

3.9/100

Profitability

11.2/100

Balance Sheet

6.8/100

Earnings Quality

20.7/100

Free Cash Flow

27.6/100

Institutional Flow

30.9/100

Revenue Scale

23.1/100

Dilution Risk

14.3/100

Email me the moment this company reports earnings

AI Research Report

Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.

Upgrade to Pro

Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

Why CDLX Scores 19/100

exact factor attribution · 2026-09-11

CDLX's composite is driven by earnings growth, held back by revenue growth and profitability. Bars show each factor's exact push vs. a median company, using the same weights the ranking engine applies.

Earnings growth

+1.8 pts

86th pct

Institutional flow

-1.0 pts

31th pct

Shareholder dilution

-1.8 pts

14th pct

Earnings quality

-2.9 pts

21th pct

Free cash flow

-3.4 pts

28th pct

Scale

-4.0 pts

23th pct

Capital efficiency

-4.3 pts

7th pct

Profitability

-5.8 pts

11th pct

Revenue growth

-9.2 pts

4th pct

Factor percentiles are cross-sectional ranks across the ~2,800-stock scored universe, computed from SEC EDGAR filings. Not investment advice.

CDLX Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for Cardlytics, Inc. (CDLX), a Technology sector company. 13F Pro's AI-powered ranking engine scores CDLX at 19.4/100 on a 32-signal composite quality model, placing it at rank #2,795 of 2,962 stocks — the bottom half of the AI-ranked universe. Areas of concern include revenue growth (3.9) and balance sheet strength (6.8), which score below median versus the broader universe. Shareholder dilution risk is elevated at 14.3/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Cardlytics, Inc. reports quarterly revenue of $36.9M, net income of $-14.9M, free cash flow of $-8.6M. Top institutional holders of CDLX by reported 13-F value include PenderFund Capital Management Ltd., Context Capital Management, 683 Capital Management, based on the most recent SEC filings. CDLX trades on the Nasdaq exchange and files with the SEC under CIK 1666071. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CDLX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Cardlytics, Inc. directly from SEC EDGAR. Cardlytics, Inc.'s 13F Pro composite quality score has ranged between 16 and 33 since 2021, currently 19.4 — a declining long-term trajectory across 68 quarterly and live scoring snapshots.

✦

Fun facts about Cardlytics, Inc.

Quirks, history, and lore behind CDLX — the kind of stuff that makes a stock memorable.

1
The Basics
U.S. ad-tech company · listed on Nasdaq · headquartered in Atlanta, Georgia · serving the financial services and marketing industries.
2
The Numbers
Annual revenue in the low hundreds of millions of dollars, but the company has spent years burning cash while scaling — profitability remains the white whale.
3
The History
Founded in 2008, it went public around 2018 and built its entire business on a novel idea: use bank transaction data to target and measure advertising.
4
The Secret
Its secret sauce is sitting inside your credit and debit card purchase history — it works with banks to turn your spending patterns into targeted purchase-based ads.
5
The Lore
The platform reaches consumers through their own banking apps and statements, meaning the ad appears right where you just checked your balance — hard to ignore, impossible to block.
6
The Giveaway
Its name is a portmanteau of cards and analytics — because when your whole business model is mining bank card data for advertisers, you might as well wear it on your sleeve.

▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q2 2026

$36.9M

Net Income

Q2 2026

$-14.9M

Free Cash Flow

Q2 2026

$-8.6M

ROIC

Q2 2026

-12.9%

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

-16.2% YoY

$233.3MFY 2025

FY22 $298.5MFY23 $309.2MFY24 $278.3MFY25 $233.3M

Net Income

+45.3% YoY

$-103.5MFY 2025

FY22 $-465.3MFY23 $-134.7MFY24 $-189.3MFY25 $-103.5M

Operating Income

+47.9% YoY

$-101.8MFY 2025

FY22 $-457.8MFY23 $-135.7MFY24 $-195.5MFY25 $-101.8M

EPS (Diluted)

+50.1% YoY

$-1.95FY 2025

FY22 $-13.92FY23 $-3.69FY24 $-3.91FY25 $-1.95

Total Assets

-27.3% YoY

$285.6MFY 2025

FY22 $691.2MFY23 $574.1MFY24 $392.7MFY25 $285.6M

Total Debt

-21.0% YoY

$208.9MFY 2025

FY22 $226.0MFY23 $257.5MFY24 $264.4MFY25 $208.9M

Op. Cash Flow

+205.3% YoY

$9.3MFY 2025

FY22 $-53.9MFY23 $-185.0KFY24 $-8.8MFY25 $9.3M

Free Cash Flow

+184.8% YoY

$8.8MFY 2025

FY22 $-55.1MFY23 $-852.0KFY24 $-10.4MFY25 $8.8M

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$233.3M -16.2%	$278.3M -10.0%	$309.2M +3.6%	$298.5M +11.8%	$267.1M +42.9%	$186.9M
Net Income	$-103.5M +45.3%	$-189.3M -40.5%	$-134.7M +71.0%	$-465.3M -261.9%	$-128.6M -132.0%	$-55.4M
Operating Income	$-101.8M +47.9%	$-195.5M -44.1%	$-135.7M +70.4%	$-457.8M -273.4%	$-122.6M -127.4%	$-53.9M
EPS (Diluted)	$-1.95 +50.1%	$-3.91 -6.0%	$-3.69 +73.5%	$-13.92	—	—
Total Assets	$285.6M -27.3%	$392.7M -31.6%	$574.1M -16.9%	$691.2M -45.3%	$1.26B +199.1%	$422.5M
Total Debt	$208.9M -21.0%	$264.4M +2.7%	$257.5M +13.9%	$226.0M +22.6%	$184.4M +6.0%	$174.0M
Operating Cash Flow	$9.3M +205.3%	$-8.8M -4669.7%	$-185.0K +99.7%	$-53.9M -39.9%	$-38.5M -407.0%	$-7.6M
Free Cash Flow	$8.8M +184.8%	$-10.4M -1119.0%	$-852.0K +98.5%	$-55.1M -32.3%	$-41.6M -220.1%	$-13.0M

Get alerted when CDLX's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Cardlytics, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of CDLX

PenderFund Capital Management Ltd.
$15.5M53,802,000 sh
Context Capital Management, LLC
$12.4M42,939,000 sh
683 Capital Management, LLC
$5.9M20,500,000 sh
CAPSTONE INVESTMENT ADVISORS, LLC
$4.6M11,145,000 sh
WOLVERINE ASSET MANAGEMENT LLC
$3.6M12,379,000 sh
SUSQUEHANNA INTERNATIONAL GROUP, LLP
$3.2M710,300 sh
CAS Investment Partners, LLC
$2.1M470,986 sh
TENOR CAPITAL MANAGEMENT Co., L.P.
$1.6M5,000,000 sh
DeepCurrents Investment Group LLC
$1.2M4,435,000 sh
VANGUARD CAPITAL MANAGEMENT LLC
$981.6K218,612 sh

Fund	Value	Shares
PenderFund Capital Management Ltd.	$15.5M	53,802,000
Context Capital Management, LLC	$12.4M	42,939,000
683 Capital Management, LLC	$5.9M	20,500,000
CAPSTONE INVESTMENT ADVISORS, LLC	$4.6M	11,145,000
WOLVERINE ASSET MANAGEMENT LLC	$3.6M	12,379,000
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$3.2M	710,300
CAS Investment Partners, LLC	$2.1M	470,986
TENOR CAPITAL MANAGEMENT Co., L.P.	$1.6M	5,000,000
DeepCurrents Investment Group LLC	$1.2M	4,435,000
VANGUARD CAPITAL MANAGEMENT LLC	$981.6K	218,612

Companies Similar to CDLX

Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.

VERI

Veritone, Inc.

AI score

Similar quality profile · 2 shared holders

Context Capital Management, LLC TENOR CAPITAL MANAGEMENT Co., L.P.

LPSN

LIVEPERSON INC

AI score

Similar quality profile

SMRT

SmartRent, Inc.

AI score

Similar quality profile · 2 shared holders

Quinn Opportunity Partners LLC Point72 Asia (Singapore) Pte. Ltd.

WOLF

WOLFSPEED, INC.

AI score

Similar quality profile · 3 shared holders

PenderFund Capital Management Ltd.Context Capital Management, LLC DeepCurrents Investment Group LLC

EVH

Evolent Health, Inc.

AI score

Similar quality profile · 5 shared holders

PenderFund Capital Management Ltd.Context Capital Management, LLC TENOR CAPITAL MANAGEMENT Co., L.P.

UPLD

Upland Software, Inc.

AI score

Similar quality profile · 1 shared holders

RBF Capital, LLC

DMRC.R1438231

Digimarc CORP

AI score

Similar quality profile · 1 shared holders

Point72 Asia (Singapore) Pte. Ltd.

AIRG

AIRGAIN INC

AI score

Similar quality profile · 1 shared holders

RBF Capital, LLC

Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.

More Technology Companies

View all Technology →

AGILENT TECHNOLOGIES, INC.

AAOI

APPLIED OPTOELECTRONICS, INC.

AAPL

Apple Inc.

ABNB

Airbnb, Inc.

ACCL

Acco Group Holdings Ltd

ACCS

ACCESS Newswire Inc.

ACFN

ACORN ENERGY, INC.

ACIW

ACI WORLDWIDE, INC.

Put CDLX on your watchlist

Track score changes the day Cardlytics, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is CDLX a good stock to buy?

13F Pro's AI-powered analysis of Cardlytics, Inc. (CDLX) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Technology sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for CDLX are available on the CDLX stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. CDLX is classified as a small company.

Which hedge funds own CDLX?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling CDLX. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Cardlytics, Inc.'s investment landscape.